Journey Medical (DERM) Accounts Payables: 2020-2025
Historic Accounts Payables for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $11.6 million.
- Journey Medical's Accounts Payables fell 24.66% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 24.66%. This contributed to the annual value of $16.1 million for FY2024, which is 11.57% down from last year.
- Latest data reveals that Journey Medical reported Accounts Payables of $11.6 million as of Q3 2025, which was down 9.39% from $12.8 million recorded in Q2 2025.
- Journey Medical's 5-year Accounts Payables high stood at $43.7 million for Q1 2023, and its period low was $11.6 million during Q3 2025.
- For the 3-year period, Journey Medical's Accounts Payables averaged around $20.2 million, with its median value being $15.3 million (2024).
- Per our database at Business Quant, Journey Medical's Accounts Payables surged by 1,140.46% in 2021 and then crashed by 64.86% in 2024.
- Quarterly analysis of 5 years shows Journey Medical's Accounts Payables stood at $22.8 million in 2021, then surged by 60.31% to $36.6 million in 2022, then plummeted by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.1 million in 2024, then declined by 24.66% to $11.6 million in 2025.
- Its Accounts Payables was $11.6 million in Q3 2025, compared to $12.8 million in Q2 2025 and $14.4 million in Q1 2025.